AstraZeneca directors unmoved by shareholder calls to reopen Pfizer talks

AXA Investment Managers and Legal & General express disappointment with AstraZeneca's refusal to negotiate

AstraZeneca's directors remained defiant on Wednesday night in the face of calls from one of the drugs company's biggest shareholders to reopen talks with its unwanted suitor, the US-based Pfizer group.

With less than five days left until the 5pm deadline on Monday when Pfizer has to table a firm offer or walk away for six months, AXA Investment Managers and Legal & General expressed disappointment with AstraZeneca's refusal to negotiate with its US rival.

Continue reading...



Source Uk | The Guardian http://ift.tt/1kpJSTg

http://ift.tt/eA8V8J